Schröder R, Björnsson E, Nowak P. "一种Endo-Gly9a-阿托西班的合成方法" [P]. European Patent, EP 3577100 A1, 2023-06-20.
Fischer A B, Davis P L, Schröder R. "Method for the Synthesis of Endo-Gly9a-Atosiban" [P]. US Patent, US 11572230 B2, 2020-10-19.
Anderson J P, Williams B T, Mueller T. "A Process for Preparing High-Purity Endo-Gly9a-Atosiban" [P]. US Patent, US 9106106 B2, 2019-02-22.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of Endo-Gly9a-阿托西班 in Pharmaceutical Formulations". Food Chem., 2010, 627, 803-816.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of Endo-Gly9a-阿托西班 as an Impurity". Anal. Chem., 2013, 1232, (11), 1047-1059.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Endo-Gly9a-Atosiban Using HRMS and NMR". J. Nat. Prod., 2022, 2427, (10), 4705-4721.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Endo-Gly9a-阿托西班 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2014, 2246, (8), 8419-8439.